137 related articles for article (PubMed ID: 30010344)
1. Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.
Madia VN; Messore A; Pescatori L; Saccoliti F; Tudino V; De Leo A; Bortolami M; Scipione L; Costi R; Rivara S; Scalvini L; Mor M; Ferrara FF; Pavoni E; Roscilli G; Cassinelli G; Milazzo FM; Battistuzzi G; Di Santo R; Giannini G
J Med Chem; 2018 Aug; 61(15):6918-6936. PubMed ID: 30010344
[TBL] [Abstract][Full Text] [Related]
2. Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.
Messore A; Madia VN; Pescatori L; Saccoliti F; Tudino V; De Leo A; Bortolami M; De Vita D; Scipione L; Pepi F; Costi R; Rivara S; Scalvini L; Mor M; Ferrara FF; Pavoni E; Roscilli G; Cassinelli G; Milazzo FM; Battistuzzi G; Di Santo R; Giannini G
J Med Chem; 2018 Dec; 61(23):10834-10859. PubMed ID: 30412404
[TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
[TBL] [Abstract][Full Text] [Related]
4. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.
Pala D; Rivara S; Mor M; Milazzo FM; Roscilli G; Pavoni E; Giannini G
Glycobiology; 2016 Jun; 26(6):640-54. PubMed ID: 26762172
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
7. Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.
Rondanin R; Fochi S; Baruchello R; Bernardi T; Oliva P; Semeraro F; Simoni D; Giannini G
Bioorg Med Chem Lett; 2017 Sep; 27(18):4421-4425. PubMed ID: 28811133
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
9. Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer Therapy.
Zubkova OV; Ahmed YA; Guimond SE; Noble SL; Miller JH; Alfred Smith RA; Nurcombe V; Tyler PC; Weissmann M; Vlodavsky I; Turnbull JE
ACS Chem Biol; 2018 Dec; 13(12):3236-3242. PubMed ID: 30480427
[TBL] [Abstract][Full Text] [Related]
10. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
Zhou Z; Bates M; Madura JD
Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
[TBL] [Abstract][Full Text] [Related]
11. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase.
Wilson JC; Laloo AE; Singh S; Ferro V
Biochem Biophys Res Commun; 2014 Jan; 443(1):185-8. PubMed ID: 24291708
[TBL] [Abstract][Full Text] [Related]
12. New classes of potent heparanase inhibitors from ligand-based virtual screening.
Pala D; Scalvini L; Elisi GM; Lodola A; Mor M; Spadoni G; Ferrara FF; Pavoni E; Roscilli G; Milazzo FM; Battistuzzi G; Rivara S; Giannini G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1685-1696. PubMed ID: 32907434
[TBL] [Abstract][Full Text] [Related]
13. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
Gandhi NS; Freeman C; Parish CR; Mancera RL
Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies.
Khan KM; Rahim F; Wadood A; Taha M; Khan M; Naureen S; Ambreen N; Hussain S; Perveen S; Choudhary MI
Bioorg Med Chem Lett; 2014 Apr; 24(7):1825-9. PubMed ID: 24602903
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a pseudo-disaccharide library and its application to the characterisation of the heparanase catalytic site.
Vinader V; Haji-Abdullahi MH; Patterson LH; Afarinkia K
PLoS One; 2013; 8(11):e82111. PubMed ID: 24260588
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Molecular Docking and β-Glucuronidase Inhibitory Potential of Indole Base Oxadiazole Derivatives.
Anouar EH; Moustapha ME; Taha M; Geesi MH; Farag ZR; Rahim F; Almandil NB; Farooq RK; Nawaz M; Mosaddik A
Molecules; 2019 Mar; 24(5):. PubMed ID: 30857263
[TBL] [Abstract][Full Text] [Related]
17. Involvement of disulfide bond formation in the activation of heparanase.
Simizu S; Suzuki T; Muroi M; Lai NS; Takagi S; Dohmae N; Osada H
Cancer Res; 2007 Aug; 67(16):7841-9. PubMed ID: 17699790
[TBL] [Abstract][Full Text] [Related]
18. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
Schoenfeld AK; Vierfuß S; Lühn S; Alban S
J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
[TBL] [Abstract][Full Text] [Related]
19. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
20. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation.
Ferro V; Hammond E; Fairweather JK
Mini Rev Med Chem; 2004 Aug; 4(6):693-702. PubMed ID: 15279603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
